Version 2 (modified by luciano.ramalho, 4 years ago)

--

Field 13. Intervention(s)

WHO description

Enter the specific name of the intervention(s) and the comparator/control(s) being studied. Use the International Non-Proprietary Name if possible (not brand/trade names). For an unregistered drug, the generic name, chemical name, or company serial number is acceptable. If the intervention consists of several separate treatments, list them all in one line separated by commas (e.g., "low-fat diet, exercise").

Schema

Validation

Labels

EN:

PT:

ES:

Sample Values

sample 1
sample 2
sample 3

Discussion

Notes taken by LR 2009-08-06:

schema
repeating, two sub-fields: intervention_type: string, editable, choices as above; intervention_description: string, editable
choices
intervention_type: from "tipo de intervenção" from Plataforma Brasil, including "other"
intervention_type
drug
intervention_description
uso
intervention_description_administration_route
(ask Claudio Nishizawa)
intervention_description_pharmaceutical_form
(ask Claudio Nishizawa)
intervention_code_dci
(ask Claudio Nishizawa, content only in English and Spanish)
intervention_code_devices
(ask Claudio Nishizawa)
control_intervention_type
check ANZCTR (ask Laguardia)
control_intervention_description
check ANZCTR (ask Laguardia)
custom_intervention_code_dcb
(ask Claudio Nishizawa)
custom_intervention_code_homeopatia
(ask Claudio Nishizawa)
custom_intervention_code_tabela_fitoterapicos
(ask Ricardo Gamarski)

(use this area to post further suggestions)


Part of: TrialRegistrationDataSet